This publication list includes only the more recent review articles and is updated every day via PubMed. A list including the research articles is also available. IDIGH principal investigators are in bold.

CTB

  1. McDonald, E. G., Butler-Laporte, G., Del Corpo, O., Hsu, J. M., Lawandi, A., Senecal, J., Sohani, Z. N., Cheng, M. P. & Lee, T. C. (2021). On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence. Open forum infectious diseases, vol. 8, p. ofab545.
  2. Yan, J., Ouyang, J., Isnard, S., Zhou, X., Harypursat, V., Routy, J.-P. & Chen, Y. (2021). Alcohol Use and Abuse Conspires With HIV Infection to Aggravate Intestinal Dysbiosis and Increase Microbial Translocation in People Living With HIV: A Review. Frontiers in immunology, vol. 12, p. 741658.
  3. Carvalho Cabral, P., Tekade, K., Stegeman, S. K., Olivier, M. & Cermakian, N. (2021). The involvement of host circadian clocks in the regulation of the immune response to parasitic infections in mammals. Parasite immunology, p. e12903.
  4. Elkrief, A., Wu, J. T., Jani, C., Enriquez, K. T., Glover, M., Shah, M. R., Shaikh, H. G., Beeghly-Fadiel, A., French, B., Jhawar, S. R., Johnson, D. B., McKay, R. R., Rivera, D. R., Reuben, D. Y., Shah, S., Tinianov, S. L., Vinh, D. C., Mishra, S. & Warner, J. L. (2021). Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer. Cancer discovery.
  5. Mouhoub, E., Domenech, P., Ndao, M. & Reed, M. B. (2021). The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview. Frontiers in microbiology, vol. 12, p. 757858.
  6. Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., O'Farrelly, C., Novelli, G., Rodríguez-Gallego, C., Haerynck, F., Prando, C., Pujol, A., COVID Human Genetic Effort, Su, H. C., Casanova, J.-L. & Spaan, A. N. (2021). A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature immunology.
  7. Sonzogni-Desautels, K. & Ndao, M. (2021). Will Auranofin Become a Golden New Treatment Against COVID-19?. Frontiers in immunology, vol. 12, p. 683694.
  8. Lange, C., Aaby, P., Behr, M. A., Donald, P. R., Kaufmann, S. H. E., Netea, M. G. & Mandalakas, A. M. (2022). 100 years of Mycobacterium bovis bacille Calmette-Guérin. The Lancet. Infectious diseases, vol. 22, p. e2-e12.
  9. Senécal, J., Smyth, E., Del Corpo, O., Hsu, J. M., Amar-Zifkin, A., Bergeron, A., Cheng, M. P., Butler-Laporte, G., McDonald, E. G. & Lee, T. C. (2022). Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 28, p. 23-30.
  10. Royston, L., Isnard, S., Lin, J. & Routy, J.-P. (2021). Cytomegalovirus as an Uninvited Guest in the Response to Vaccines in People Living with HIV. Viruses, vol. 13.
  11. Gyorkos, T. W., Carabin, H., Phillip, M., Benedict, L., Davis, A., Hatcher Roberts, J., Wasan, K. M., Ndao, M. & Krentel, A. (2021). Canadian contributions to research on neglected tropical diseases. PLoS neglected tropical diseases, vol. 15, p. e0009476.
  12. Kontsevaya, I., Lange, C., Comella-Del-Barrio, P., Coarfa, C., DiNardo, A. R., Gillespie, S. H., Hauptmann, M., Leschczyk, C., Mandalakas, A. M., Martinecz, A., Merker, M., Niemann, S., Reimann, M., Rzhepishevska, O., Schaible, U. E., Scheu, K. M., Schurr, E., Abel Zur Wiesch, P. & Heyckendorf, J. (2021). Perspectives for systems biology in the management of tuberculosis. European respiratory review : an official journal of the European Respiratory Society, vol. 30.
  13. Knight, V., Heimall, J. R., Chong, H., Nandiwada, S. L., Chen, K., Lawrence, M. G., Sadighi Akha, A. A., Kumánovics, A., Jyonouchi, S., Ngo, S. Y., Vinh, D. C., Hagin, D., Forbes Satter, L. R., Marsh, R. A., Chiang, S. C. C., Willrich, M. A. V., Frazer-Abel, A. A. & Rider, N. L. (2021). A Toolkit and Framework for Optimal Laboratory Evaluation of Individuals with Suspected Primary Immunodeficiency. The journal of allergy and clinical immunology. In practice, vol. 9, p. 3293-3307.e6.
  14. Isnard, S., Lin, J., Bu, S., Fombuena, B., Royston, L. & Routy, J.-P. (2021). Gut Leakage of Fungal-Related Products: Turning Up the Heat for HIV Infection. Frontiers in immunology, vol. 12, p. 656414.
  15. Dong, G., Wagner, V., Minguez-Menendez, A., Fernandez-Prada, C. & Olivier, M. (2021). Extracellular vesicles and leishmaniasis: Current knowledge and promising avenues for future development. Molecular immunology, vol. 135, p. 73-83.
  16. Lee, T., Cau, A., Cheng, M. P., Levin, A., Lee, T. C., Vinh, D. C., Lamontagne, F., Singer, J., Walley, K. R., Murthy, S., Patrick, D., Rewa, O. G., Winston, B. W., Marshall, J., Boyd, J., Tran, K., Kalil, A. C., Mcculoh, R., Fowler, R., Luther, J. M., Russell, J. A. & ARBs CORONA (2021). Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors. CJC open, vol. 3, p. 965-975.
  17. Roussel, L. & Vinh, D. C. (2021). ICOSL in host defense at epithelial barriers: lessons from ICOSLG deficiency. Current opinion in immunology, vol. 72, p. 21-26.
  18. Dagenais-Lussier, X., Loucif, H., Beji, C., Telittchenko, R., Routy, J.-P. & van Grevenynghe, J. (2021). Latest developments in tryptophan metabolism: Understanding its role in B cell immunity. Cytokine & growth factor reviews, vol. 59, p. 111-117.
  19. Munoz, F. M., Cramer, J. P., Dekker, C. L., Dudley, M. Z., Graham, B. S., Gurwith, M., Law, B., Perlman, S., Polack, F. P., Spergel, J. M., Van Braeckel, E., Ward, B. J., Didierlaurent, A. M., Lambert, P. H. & Brighton Collaboration Vaccine-associated Enhanced Disease Working Group (2021). Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine, vol. 39, p. 3053-3066.
  20. Grover, P., Goel, P. N., Piccirillo, C. A. & Greene, M. I. (2021). FOXP3 and Tip60 Structural Interactions Relevant to IPEX Development Lead to Potential Therapeutics to Increase FOXP3 Dependent Suppressor T Cell Functions. Frontiers in pediatrics, vol. 9, p. 607292.
  21. Zriek, F., Di Battista, J. A. & Alaaeddine, N. (2021). Mesenchymal Stromal Cell Secretome: Immunomodulation, Tissue Repair and Effects on Neurodegenerative Conditions. Current stem cell research & therapy, vol. 16, p. 656-669.
  22. Ahmed, D. S., Isnard, S., Lin, J., Routy, B. & Routy, J.-P. (2021). GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer. Journal of Cancer, vol. 12, p. 1125-1132.
  23. Peng, X., Ouyang, J., Isnard, S., Lin, J., Fombuena, B., Zhu, B. & Routy, J.-P. (2020). Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System. Frontiers in immunology, vol. 11, p. 596631.
  24. Torrecilhas, A. C., Soares, R. P., Schenkman, S., Fernández-Prada, C. & Olivier, M. (2020). Extracellular Vesicles in Trypanosomatids: Host Cell Communication. Frontiers in cellular and infection microbiology, vol. 10, p. 602502.
  25. Ratnarajah, K., Le, M., Muntyanu, A., Mathieu, S., Nigen, S., Litvinov, I. V., Jack, C. S. & Netchiporouk, E. (2020). Inhibition of IL-13: A New Pathway for Atopic Dermatitis [Formula: see text]. Journal of cutaneous medicine and surgery, vol. 25, p. 315-328.

 

CORE

  1. McDonald, E. G., Butler-Laporte, G., Del Corpo, O., Hsu, J. M., Lawandi, A., Senecal, J., Sohani, Z. N., Cheng, M. P. & Lee, T. C. (2021). On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence. Open forum infectious diseases, vol. 8, p. ofab545.
  2. Mo, S., Malhamé, I., Schneiderman, M. & Vinet, É. (2021). Pregnancy termination in patients with rheumatic diseases. Arthritis care & research.
  3. Gorodensky, J. H., Bernatsky, S., Afif, W., Filion, K. B. & Vinet, É. (2021). Ustekinumab safety in pregnancy: a comprehensive review. Arthritis care & research.
  4. Senécal, J., Smyth, E., Del Corpo, O., Hsu, J. M., Amar-Zifkin, A., Bergeron, A., Cheng, M. P., Butler-Laporte, G., McDonald, E. G. & Lee, T. C. (2022). Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 28, p. 23-30.
  5. Lazarus, J. V., Safreed-Harmon, K., Kamarulzaman, A., Anderson, J., Leite, R. B., Behrens, G., Bekker, L.-G., Bhagani, S., Brown, D., Brown, G., Buchbinder, S., Caceres, C., Cahn, P. E., Carrieri, P., Caswell, G., Cooke, G. S., Monforte, A. D., Dedes, N., Del Amo, J., Elliott, R., El-Sadr, W. M., Fuster-Ruiz de Apodaca, M. J., Guaraldi, G., Hallett, T., Harding, R., Hellard, M., Jaffar, S., Kall, M., Klein, M., Lewin, S. R., Mayer, K., Pérez-Molina, J. A., Moraa, D., Naniche, D., Nash, D., Noori, T., Pozniak, A., Rajasuriar, R., Reiss, P., Rizk, N., Rockstroh, J., Romero, D., Sabin, C., Serwadda, D. & Waters, L. (2021). Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV. Nature communications, vol. 12, p. 4450.
  6. Gyorkos, T. W., Carabin, H., Phillip, M., Benedict, L., Davis, A., Hatcher Roberts, J., Wasan, K. M., Ndao, M. & Krentel, A. (2021). Canadian contributions to research on neglected tropical diseases. PLoS neglected tropical diseases, vol. 15, p. e0009476.
  7. Cao, X.-F., Li, Y., Xin, H.-N., Zhang, H.-R., Pai, M. & Gao, L. (2021). Application of artificial intelligence in digital chest radiography reading for pulmonary tuberculosis screening. Chronic diseases and translational medicine, vol. 7, p. 35-40.
  8. Shengir, M., Elgara, M. & Sebastiani, G. (2021). Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond. World journal of gastroenterology, vol. 27, p. 1959-1972.
  9. Akiyama, M. J., Kronfli, N., Cabezas, J., Sheehan, Y., Thurairajah, P. H., Lines, R., Lloyd, A. R. & International Network on Health and Hepatitis in Substance Users–Prisons Network (2021). Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework. The lancet. Gastroenterology & hepatology, vol. 6, p. 391-400.
  10. Amoako, A., Ortiz-Paredes, D., Engler, K., Lebouché, B. & Klein, M. B. (2021). Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis. The International journal on drug policy, vol. 96, p. 103247.
  11. Nissen, C. B., Sciascia, S., de Andrade, D., Atsumi, T., Bruce, I. N., Cron, R. Q., Hendricks, O., Roccatello, D., Stach, K., Trunfio, M., Vinet, É. & Schreiber, K. (2021). The role of antirheumatics in patients with COVID-19. The Lancet. Rheumatology, vol. 3, p. e447-e459.
  12. Houlding, E., Mate, K. K. V., Engler, K., Ortiz-Paredes, D., Pomey, M.-P., Cox, J., Hijal, T. & Lebouché, B. (2021). Barriers to Use of Remote Monitoring Technologies Used to Support Patients With COVID-19: Rapid Review. JMIR mHealth and uHealth, vol. 9, p. e24743.
  13. Chang, J., Cattelan, L., Ben-Shoshan, M., Le, M. & Netchiporouk, E. (2021). Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines. Journal of asthma and allergy, vol. 14, p. 187-199.
  14. Wasserman, R. L., Factor, J., Windom, H. H., Abrams, E. M., Begin, P., Chan, E. S., Greenhawt, M., Hare, N., Mack, D. P., Mansfield, L., Ben-Shoshan, M., Stukus, D. R., Leek, T. V. & Shaker, M. (2021). An Approach to the Office-Based Practice of Food Oral Immunotherapy. The journal of allergy and clinical immunology. In practice, vol. 9, p. 1826-1838.e8.
  15. Bartlett, S. R., Buxton, J., Palayew, A., Picchio, C. A., Janjua, N. Z. & Kronfli, N. (2021). Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated in Canada: Leaving No One Behind in the Direct-Acting Antiviral Era. Clinical liver disease, vol. 17, p. 75-80.
  16. Ji, X., Chow, E., Abdelhamid, K., Naumova, D., Mate, K. K. V., Bergeron, A. & Lebouché, B. (2021). Utility of mobile technology in medical interpretation: A literature review of current practices. Patient education and counseling, vol. 104, p. 2137-2145.
  17. Pullen, M. F., Pastick, K. A., Williams, D. A., Nascene, A. A., Bangdiwala, A. S., Okafor, E. C., Hullsiek, K. H., Skipper, C. P., Lofgren, S. M., Engen, N., Abassi, M., McDonald, E. G., Lee, T. C., Rajasingham, R. & Boulware, D. R. (2021). Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic. Open forum infectious diseases, vol. 8, p. ofaa602.
  18. D'Silva, K. M., Mehta, R., Mitchell, M., Lee, T. C., Singhal, V., Wilson, M. G. & McDonald, E. G. (2021). Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
  19. Laurie, C., El-Zein, M., Coutlée, F., de Pokomandy, A. & Franco, E. L. (2021). Carrageenan as a Preventive Agent Against Human Papillomavirus Infection: A Narrative Review. Sexually transmitted diseases, vol. 48, p. 458-465.
  20. Jeimy, S., Ben-Shoshan, M., Abrams, E. M., Ellis, A. K., Connors, L. & Wong, T. (2020). Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, vol. 16, p. 95.
  21. Kpokiri, E. E., Marley, G., Tang, W., Fongwen, N., Wu, D., Berendes, S., Ambil, B., Loveday, S.-J., Sampath, R., Walker, J. S., Matovu, J. K. B., Boehme, C., Pai, N. P. & Tucker, J. D. (2020). Diagnostic Infectious Diseases Testing Outside Clinics: A Global Systematic Review and Meta-analysis. Open forum infectious diseases, vol. 7, p. ofaa360.
  22. Cervo, A., Shengir, M., Patel, K. & Sebastiani, G. (2020). NASH in HIV. Current HIV/AIDS reports, vol. 17, p. 601-614.
  23. Gonçalo, M., Gimenéz-Arnau, A., Al-Ahmad, M., Ben-Shoshan, M., Bernstein, J. A., Ensina, L. F., Fomina, D., Galvàn, C. A., Godse, K., Grattan, C., Hide, M., Katelaris, C. H., Khoshkhui, M., Kocatürk, E., Kulthanan, K., Medina, I., Nasr, I., Peter, J., Staubach, P., Wang, L., Weller, K. & Maurer, M. (2021). The global burden of chronic urticaria for the patient and society. The British journal of dermatology, vol. 184, p. 226-236.
  24. Jolicoeur, E. M., Dendukuri, N., Belisle, P., Range, G., Souteyrand, G., Bouisset, F., Zemour, G., Delarche, N., Harbaoui, B., Schampaert, E., Kouz, S., Cayla, G., Roubille, F., Boueri, Z., Mansour, S., Marcaggi, X., Tardif, J.-C., McGillion, M., Tanguay, J.-F., Brophy, J., Yu, C. W., Berry, C., Carrick, D., Høfsten, D. E., Engstrøm, T., Kober, L., Kelbæk, H. & Belle, L. (2020). Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial. The Canadian journal of cardiology, vol. 36, p. 1805-1814.
  25. Pai, N. P., Karellis, A., Kim, J. & Peter, T. (2020). Modern diagnostic technologies for HIV. The lancet. HIV, vol. 7, p. e574-e581.

 

Clinical

  1. Guillo, L., Abreu, M., Panaccione, R., Sandborn, W. J., Azevedo, V. F., Gensler, L., Moghaddam, B., Ahuja, V., Ali, S. A., Allez, M., Ananthakrishnan, A. N., Bhattacharya, A., Dubinsky, M., Griffiths, A., Hart, A., Korelitz, B., Kotze, P. G., Koutroubakis, I. E., Lakatos, P. L., Lindsay, J. O., Magro, F., Mantzaris, G. J., Ng, S. C., O'Morain, C., Panés, J., Parigi, T., Ran, Z., Rogler, G., Rubin, D. T., Sachar, D. B., Siegmund, B., Steinwurz, F., Tysk, C., Vavricka, S., Verstraete, S. G., Brezin, A. P., Haemel, A. K., Dignass, A., Sands, B. E., Danese, S. & Peyrin-Biroulet, L. (2022). Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. The lancet. Gastroenterology & hepatology.
  2. Papamichael, K., Afif, W., Drobne, D., Dubinsky, M. C., Ferrante, M., Irving, P. M., Kamperidis, N., Kobayashi, T., Kotze, P. G., Lambert, J., Noor, N. M., Roblin, X., Roda, G., Vande Casteele, N., Yarur, A. J., Arebi, N., Danese, S., Paul, S., Sandborn, W. J., Vermeire, S., Cheifetz, A. S., Peyrin-Biroulet, L. & International Consortium for Therapeutic Drug Monitoring (2022). Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives. The lancet. Gastroenterology & hepatology, vol. 7, p. 171-185.
  3. McDonald, E. G., Butler-Laporte, G., Del Corpo, O., Hsu, J. M., Lawandi, A., Senecal, J., Sohani, Z. N., Cheng, M. P. & Lee, T. C. (2021). On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence. Open forum infectious diseases, vol. 8, p. ofab545.
  4. Wetwittayakhlang, P., Lontai, L., Gonczi, L., Golovics, P. A., Hahn, G. D., Bessissow, T. & Lakatos, P. L. (2021). Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?. Journal of clinical medicine, vol. 10.
  5. Gorodensky, J. H., Bernatsky, S., Afif, W., Filion, K. B. & Vinet, É. (2021). Ustekinumab safety in pregnancy: a comprehensive review. Arthritis care & research.
  6. Albader, F., Golovics, P. A., Gonczi, L., Bessissow, T., Afif, W. & Lakatos, P. L. (2021). Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring. World journal of gastroenterology, vol. 27, p. 6231-6247.
  7. Jones, J. L., Tse, F., Carroll, M. W., deBruyn, J. C., McNeil, S. A., Pham-Huy, A., Seow, C. H., Barrett, L. L., Bessissow, T., Carman, N., Melmed, G. Y., Vanderkooi, O. G., Marshall, J. K. & Benchimol, E. I. (2021). Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines. Journal of the Canadian Association of Gastroenterology, vol. 4, p. e72-e91.
  8. Benchimol, E. I., Tse, F., Carroll, M. W., deBruyn, J. C., McNeil, S. A., Pham-Huy, A., Seow, C. H., Barrett, L. L., Bessissow, T., Carman, N., Melmed, G. Y., Vanderkooi, O. G., Marshall, J. K. & Jones, J. L. (2021). Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines. Journal of the Canadian Association of Gastroenterology, vol. 4, p. e59-e71.
  9. Senécal, J., Smyth, E., Del Corpo, O., Hsu, J. M., Amar-Zifkin, A., Bergeron, A., Cheng, M. P., Butler-Laporte, G., McDonald, E. G. & Lee, T. C. (2022). Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 28, p. 23-30.
  10. Cheifetz, A. S., Abreu, M. T., Afif, W., Cross, R. K., Dubinsky, M. C., Loftus, E. V., Osterman, M. T., Saroufim, A., Siegel, C. A., Yarur, A. J., Melmed, G. Y. & Papamichael, K. (2021). A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease. The American journal of gastroenterology, vol. 116, p. 2014-2025.
  11. Muntyanu, A., Le, M., Ridha, Z., O'Brien, E., Litvinov, I. V., Lefrançois, P. & Netchiporouk, E. (2021). Novel role of long non-coding RNAs in autoimmune cutaneous disease. Journal of cell communication and signaling.
  12. Al Khoury, A., Balram, B., Bessissow, T., Afif, W., Gonczi, L., Abreu, M. & Lakatos, P. L. (2021). Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review. Digestive diseases and sciences.
  13. Lee, T., Cau, A., Cheng, M. P., Levin, A., Lee, T. C., Vinh, D. C., Lamontagne, F., Singer, J., Walley, K. R., Murthy, S., Patrick, D., Rewa, O. G., Winston, B. W., Marshall, J., Boyd, J., Tran, K., Kalil, A. C., Mcculoh, R., Fowler, R., Luther, J. M., Russell, J. A. & ARBs CORONA (2021). Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors. CJC open, vol. 3, p. 965-975.
  14. Falutz, J., Brañas, F. & Erlandson, K. M. (2021). Frailty: the current challenge for aging people with HIV. Current opinion in HIV and AIDS, vol. 16, p. 133-140.
  15. Restellini, S. & Afif, W. (2021). Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease. Journal of clinical medicine, vol. 10.
  16. Chang, J., Cattelan, L., Ben-Shoshan, M., Le, M. & Netchiporouk, E. (2021). Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines. Journal of asthma and allergy, vol. 14, p. 187-199.
  17. Murthy, S. & Lee, T. C. (2021). IL-6 blockade for COVID-19: a global scientific call to arms. The Lancet. Respiratory medicine, vol. 9, p. 438-440.
  18. Pullen, M. F., Pastick, K. A., Williams, D. A., Nascene, A. A., Bangdiwala, A. S., Okafor, E. C., Hullsiek, K. H., Skipper, C. P., Lofgren, S. M., Engen, N., Abassi, M., McDonald, E. G., Lee, T. C., Rajasingham, R. & Boulware, D. R. (2021). Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic. Open forum infectious diseases, vol. 8, p. ofaa602.
  19. D'Silva, K. M., Mehta, R., Mitchell, M., Lee, T. C., Singhal, V., Wilson, M. G. & McDonald, E. G. (2021). Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
  20. Ratnarajah, K., Le, M., Muntyanu, A., Mathieu, S., Nigen, S., Litvinov, I. V., Jack, C. S. & Netchiporouk, E. (2020). Inhibition of IL-13: A New Pathway for Atopic Dermatitis [Formula: see text]. Journal of cutaneous medicine and surgery, vol. 25, p. 315-328.
  21. Hamer, D. H., Rizwan, A., Freedman, D. O., Kozarsky, P. & Libman, M. (2020). GeoSentinel: past, present and future†. Journal of travel medicine, vol. 27.
  22. Ouchene, L., Muntyanu, A., Lavoué, J., Baron, M., Litvinov, I. V. & Netchiporouk, E. (2020). Toward Understanding of Environmental Risk Factors in Systemic Sclerosis [Formula: see text]. Journal of cutaneous medicine and surgery, vol. 25, p. 188-204.
  23. Muntyanu, A., Netchiporouk, E., Gerstein, W., Gniadecki, R. & Litvinov, I. V. (2020). Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management [Formula: see text]. Journal of cutaneous medicine and surgery, vol. 25, p. 59-76.
  24. Greenaway, C., Hargreaves, S., Barkati, S., Coyle, C. M., Gobbi, F., Veizis, A. & Douglas, P. (2020). COVID-19: Exposing and addressing health disparities among ethnic minorities and migrants. Journal of travel medicine, vol. 27.
  25. Koethe, J. R., Lagathu, C., Lake, J. E., Domingo, P., Calmy, A., Falutz, J., Brown, T. T. & Capeau, J. (2020). HIV and antiretroviral therapy-related fat alterations. Nature reviews. Disease primers, vol. 6, p. 48.

McGill

  1. Mancini, M. & Vidal, S. M. (2020). Mechanisms of Natural Killer Cell Evasion Through Viral Adaptation. Annual review of immunology, vol. 38, p. 511-539.
  2. Mancini, M. & Vidal, S. M. (2018). Insights into the pathogenesis of herpes simplex encephalitis from mouse models. Mammalian genome : official journal of the International Mammalian Genome Society, vol. 29, p. 425-445.
  3. Kang, E., Crouse, A., Chevallier, L., Pontier, S. M., Alzahrani, A., Silué, N., Campbell-Valois, F.-X., Montagutelli, X., Gruenheid, S. & Malo, D. (2018). Enterobacteria and host resistance to infection. Mammalian genome : official journal of the International Mammalian Genome Society, vol. 29, p. 558-576.